health endpoint

with SOLAR-CHS-CCHC, PCa patients from UA Cancer Center

Application of omics techniques on various health endpoints, including prostate cancer, bone health, and liver disease are listed below:

Random photos.
  • Prostates cancer, Metabolomics: Evaluating Differential Metabolic Profile by Prostate Cancer Grade among Prostate Cancer Patients
    • Conducted metabolomics analysis on 22 urine samples from prostate cancer patients who were disgnozed with prostate cancer
    • Developed and validated statistical models to compare metabolic profiles across high vs. low PCa risk group
    • Lead author for a manuscript (submitted to Metabolites) (Liu et al., 2025)
  • Bone Health, Metabolomics: TBD
    • Multi-cohort spanning from adolescence, young adulthood, to senior adulthood
    • Analyzed 304/250 plasma samples for metabolic signals in association with bone mineral densities
    • Integrated metabolomics datasets for comparative analysis
    • Lead author for a manuscript (under development)

References

2025

  1. Metabolites
    Evaluating Differential Metabolic Profile by Prostate Cancer Risk among Prostate Cancer Patients
    Tuo Liu, Jahnvi Roorkeewal, Melissa Furlong, and 6 more authors
    Metabolites, 2025